کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2592277 | 1131964 | 2016 | 9 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: Issues and approaches for ensuring effective communication on acceptable daily exposure (ADE) values applied to pharmaceutical cleaning Issues and approaches for ensuring effective communication on acceptable daily exposure (ADE) values applied to pharmaceutical cleaning](/preview/png/2592277.png)
• The methodology used to derive the acceptable daily exposure (ADE) must be current, using industry-accepted best practices.
• The ADE should be fully documented, to provide confidence, explain the rationale, and the conditions necessary for validity.
• Determination of the ADE should be performed by a qualified toxicologist with appropriate credentials and experience and be peer-reviewed.
• The ADE and supporting documentation should be reviewed periodically such that any pertinent new information is incorporated.
• Appropriate systems should be in place to ensure availability of ADEs and documentation to end users.
This manuscript centers on communication with key stakeholders of the concepts and program goals involved in the application of health-based pharmaceutical cleaning limits. Implementation of health-based cleaning limits, as distinct from other standards such as 1/1000th of the lowest clinical dose, is a concept recently introduced into regulatory domains. While there is a great deal of technical detail in the written framework underpinning the use of Acceptable Daily Exposures (ADEs) in cleaning (for example ISPE, 2010; Sargent et al., 2013), little is available to explain how to practically create a program which meets regulatory needs while also fulfilling good manufacturing practice (GMP) and other expectations. The lack of a harmonized approach for program implementation and communication across stakeholders can ultimately foster inappropriate application of these concepts. Thus, this period in time (2014–2017) could be considered transitional with respect to influencing best practice related to establishing health-based cleaning limits. Suggestions offered in this manuscript are intended to encourage full and accurate communication regarding both scientific and administrative elements of health-based ADE values used in pharmaceutical cleaning practice. This is a large and complex effort that requires: 1) clearly explaining key terms and definitions, 2) identification of stakeholders, 3) assessment of stakeholders' subject matter knowledge, 4) formulation of key messages fit to stakeholder needs, 5) identification of effective and timely means for communication, and 6) allocation of time, energy, and motivation for initiating and carrying through with communications.
Journal: Regulatory Toxicology and Pharmacology - Volume 79, Supplement 1, 15 August 2016, Pages S19–S27